OTCMKTS:TSNDF

TerrAscend Q2 2025 Earnings Results & Report

TerrAscend logo
$0.30 -0.03 (-9.93%)
As of 11/20/2026 03:59 PM Eastern

TerrAscend missed analyst earnings expectations but beat on revenue in its Q2 2025 results, released August 7, 2025. The company reported EPS of -$0.03 versus the -$0.02 consensus estimate, while revenue of $65.01 million topped the $64.87 million estimate by $140.00 thousand.

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
After Market Closes

TerrAscend EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.02
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A
EPS Beat Rate
1 of last 8 quarters

TerrAscend Revenue Results

Actual Revenue
$65.01 million
Expected Revenue
$64.87 million
Beat/Miss
Beat by +$140.00 thousand
YoY Revenue Growth
N/A

Conference Call Resources

TerrAscend Q2 2025 Earnings FAQ

TerrAscend (OTCMKTS:TSNDF) reported earnings of -$0.03 per share for Q2 2025, missing the consensus estimate of -$0.02. The report was announced on Thursday, August 7, 2025.

TerrAscend reported revenue of $65.01 million for Q2 2025, against a consensus estimate of $64.87 million.

TerrAscend Earnings Headlines

TerrAscend Reports Third Quarter 2026 Financial Results
My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
TerrAscend to Host Third Quarter 2026 Earnings Conference Call
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) is a cannabis company that cultivates, processes and sells cannabis products through retail and wholesale channels. Its offerings include cannabis flower, pre-rolls, concentrates, edibles and other consumer products, sold under a portfolio of company and partner brands.

The company operates in several U.S. markets, including Pennsylvania, New Jersey, Maryland, Michigan and California. Its retail business includes dispensaries operating under names such as The Apothecarium and Gage, alongside cultivation and processing facilities that supply its stores and other retailers.

TerrAscend serves both medical cannabis patients and adult-use consumers, with the products and services available varying by state and local regulations.

View TerrAscend Profile